Delivery Order 19AQMM23D0093-19AQMM23F3176
Award Date 9/30/23
Potential Completion Date 10/31/24
Potential Value $18M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21046, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the U.S. Secret Service to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the purchase of DuoDote auto-injector packs. The contract has a ceiling value of $70,111.80 and a completion date of May 5, 2018. Meridian Medical Technologies has a history of providing medical training devices, auto-injector kits, and nerve agent antidote treatments to various federal agencies, including the Department of...
- Meridian Medical Technologies, LLC, a Pfizer subsidiary specializing in medical countermeasures, was awarded a $992,655 delivery order by the Department of State's Bureau of Medical Services on September 30, 2024. This firm-fixed-price order, issued without set-aside designation, is for DuoDote autoinjectors—dual-agent devices containing atropine and pralidoxime chloride for treating nerve agent exposure. The delivery order is performance-based through September 29, 2025, with the place of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
- This federal contract award to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., is for the development and delivery of an FDA-approved advanced autoinjector system (AAS). The definitive contract, valued at $41,936,532.62, is a cost-plus-incentive arrangement with the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense. The award does not utilize a small business set-aside. Meridian, a manufacturer of medical countermeasures...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $16.41M firm-fixed-price delivery order to Meridian Medical Technologies, LLC for antidote treatment products, with performance extending through September 9, 2026. Meridian, a wholly-owned Pfizer subsidiary based in St. Louis, Missouri, specializes in manufacturing medical countermeasures and autoinjector devices, particularly DuoDote autoinjectors containing atropine and pralidoxime chloride for treating nerve agent...
- This is a $18,260.28 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 0.15 MG AUTO-INJECTORS. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a $8,051.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of epinephrine 0.3 mg auto-injectors, which are critical medical supplies for federal healthcare programs. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a $6,797.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of epinephrine 0.3 mg auto-injectors, a critical medical product used for emergency treatment of severe allergic reactions. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of 4,564,375 units of the epinephrine 0.3 mg auto-injector medical device, valued at $1,378.08. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC...
- This is a $1,229.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has an ultimate completion date of June 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...